BridgeMD
New treatment option for Glioblastoma
Official title Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
ClinicalTrials.gov ID: NCT06719440
What this study is testing
- What it's testing
- The objective of the BELGICA trial is to evaluate if radiotherapy could be given in a more focused manner in patients with glioblastoma in order to reduce side effects and improve quality of life. The glioblastoma (GBM) is the most common and aggressive tumour originating from the brain, affecting approximately 600 patients per year in Belgium.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants capable of giving informed consent
- Age \>= 18 y.o.
- WHO performance status 0-2
- Newly diagnosed glioblastoma (Histologically proven glioblastoma per WHO 2021 classification based on biopsy or resection )
- Indication of chemoradiotherapy confirmed by multidisciplinary tumour board
You likely can't join if
- Participation in a competing trial
- Known contraindication to undergo MRI scans
The study team makes the final eligibility decision.
Where it's taking place
- Aalst, Belgium
- Baudour, Belgium
- Bruges, Belgium
- Brussels, Belgium
- Genk, Belgium
- Ghent, Belgium
- Gilly, Belgium
- Hasselt, Belgium
- Kortrijk, Belgium
- La Louvière, Belgium
- Leuven, Belgium
- Liège, Belgium
- Mechelen, Belgium
- Montigny-le-Tilleul, Belgium
- Mouscron, Belgium
- Namur, Belgium
- Roeselare, Belgium
- Uccle, Belgium
- Verviers, Belgium
- Wilrijk, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aalst, Belgium; Baudour, Belgium; Bruges, Belgium; Brussels, Belgium; Genk, Belgium; Ghent, Belgium and 14 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.